GINKGO BIOWORKS HOLDINGS, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
GINKGO BIOWORKS HOLDINGS, INC. (DNA) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $68.21 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-26
- GINKGO BIOWORKS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $68.21M, a 13.54% increase from fiscal 2024.
- GINKGO BIOWORKS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $60.07M.
- GINKGO BIOWORKS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was -$121.31M, a 148.53% decline from fiscal 2022.
- GINKGO BIOWORKS HOLDINGS, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $249.98M, a 43.09% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $68.21M 10-K · filed 2026-02-26 |
| 2024-12-31 | $60.07M 10-K · filed 2026-02-26 |
| 2023-12-31 | -$121.31M 10-K · filed 2025-02-25 |
| 2022-12-31 | $249.98M 10-K · filed 2024-02-29 |
| 2021-12-31 | $439.28M 10-K · filed 2023-03-13 |
| 2020-12-31 | $39.08M 10-K · filed 2022-03-29 |
| 2019-12-31 | $30.23M 8-K · filed 2021-11-24 |